These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 11419818

  • 1. Management of heartburn in a large, randomized, community-based study: comparison of four therapeutic strategies.
    Howden CW, Henning JM, Huang B, Lukasik N, Freston JW.
    Am J Gastroenterol; 2001 Jun; 96(6):1704-10. PubMed ID: 11419818
    [Abstract] [Full Text] [Related]

  • 2. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
    Sontag SJ, Kogut DG, Fleischmann R, Campbell DR, Richter J, Robinson M, McFarland M, Sabesin S, Lehman GA, Castell D.
    Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463
    [Abstract] [Full Text] [Related]

  • 3. Heartburn-dominant, uninvestigated dyspepsia: a comparison of 'PPI-start' and 'H2-RA-start' management strategies in primary care--the CADET-HR Study.
    Armstrong D, Veldhuyzen van Zanten SJ, Barkun AN, Chiba N, Thomson AB, Smyth S, Sinclair P, Chakraborty B, White RJ, CADET-HR Study Group.
    Aliment Pharmacol Ther; 2005 May 15; 21(10):1189-202. PubMed ID: 15882239
    [Abstract] [Full Text] [Related]

  • 4. Comparing lansoprazole and omeprazole in onset of heartburn relief: results of a randomized, controlled trial in erosive esophagitis patients.
    Richter JE, Kahrilas PJ, Sontag SJ, Kovacs TO, Huang B, Pencyla JL.
    Am J Gastroenterol; 2001 Nov 15; 96(11):3089-98. PubMed ID: 11721754
    [Abstract] [Full Text] [Related]

  • 5. Rabeprazole versus ranitidine for the treatment of erosive gastroesophageal reflux disease: a double-blind, randomized clinical trial. Raberprazole Study Group.
    Farley A, Wruble LD, Humphries TJ.
    Am J Gastroenterol; 2000 Aug 15; 95(8):1894-9. PubMed ID: 10950032
    [Abstract] [Full Text] [Related]

  • 6. Treatment of reflux esophagitis resistant to H2-receptor antagonists with lansoprazole, a new H+/K(+)-ATPase inhibitor: a controlled, double-blind study. Lansoprazole Study Group.
    Feldman M, Harford WV, Fisher RS, Sampliner RE, Murray SB, Greski-Rose PA, Jennings DE.
    Am J Gastroenterol; 1993 Aug 15; 88(8):1212-7. PubMed ID: 8101695
    [Abstract] [Full Text] [Related]

  • 7. Treatment of gastroesophageal reflux disease: to step or not to step.
    McGuigan JE.
    Am J Gastroenterol; 2001 Jun 15; 96(6):1679-81. PubMed ID: 11419813
    [No Abstract] [Full Text] [Related]

  • 8. High- versus standard-dose ranitidine for control of heartburn in poorly responsive acid reflux disease: a prospective, controlled trial.
    Kahrilas PJ, Fennerty MB, Joelsson B.
    Am J Gastroenterol; 1999 Jan 15; 94(1):92-7. PubMed ID: 9934737
    [Abstract] [Full Text] [Related]

  • 9. Symptomatic and endoscopic outcome of heartburn 3-4.5 years after starting lansoprazole therapy: a prospective study of 142 patients.
    Abu Farsakh N.
    J Gastroenterol; 2003 Jan 15; 38(11):1042-8. PubMed ID: 14673720
    [Abstract] [Full Text] [Related]

  • 10. Lansoprazole compared with ranitidine for the treatment of nonerosive gastroesophageal reflux disease.
    Richter JE, Campbell DR, Kahrilas PJ, Huang B, Fludas C.
    Arch Intern Med; 2000 Jun 26; 160(12):1803-9. PubMed ID: 10871974
    [Abstract] [Full Text] [Related]

  • 11. Omeprazole versus ranitidine or ranitidine/metoclopramide in poorly responsive symptomatic gastroesophageal reflux disease.
    Richter JE, Sabesin SM, Kogut DG, Kerr RM, Wruble LD, Collen MJ.
    Am J Gastroenterol; 1996 Sep 26; 91(9):1766-72. PubMed ID: 8792695
    [Abstract] [Full Text] [Related]

  • 12. Step-down from multiple- to single-dose proton pump inhibitors (PPIs): a prospective study of patients with heartburn or acid regurgitation completely relieved with PPIs.
    Inadomi JM, McIntyre L, Bernard L, Fendrick AM.
    Am J Gastroenterol; 2003 Sep 26; 98(9):1940-4. PubMed ID: 14499769
    [Abstract] [Full Text] [Related]

  • 13. What is the best pharmacologic approach to managing moderate to severe heartburn?
    Melton ST, Cimmino A.
    J Fam Pract; 2001 Oct 26; 50(10):839. PubMed ID: 11674880
    [No Abstract] [Full Text] [Related]

  • 14. Helicobacter pylori infection influences symptomatic response to anti-secretory therapy in patients with GORD--crossover comparative study with famotidine and low-dose lansoprazole.
    Adachi K, Hashimoto T, Komazawa Y, Mihara T, Furuta K, Fujishiro H, Ishihara S, Amano Y, Hattori S, Kinoshita Y.
    Dig Liver Dis; 2005 Jul 26; 37(7):485-90. PubMed ID: 15975534
    [Abstract] [Full Text] [Related]

  • 15. Omeprazole versus high-dose ranitidine in mild gastroesophageal reflux disease: short- and long-term treatment. The Dutch Reflux Study Group.
    Festen HP, Schenk E, Tan G, Snel P, Nelis F.
    Am J Gastroenterol; 1999 Apr 26; 94(4):931-6. PubMed ID: 10201459
    [Abstract] [Full Text] [Related]

  • 16. Double-blind, placebo-controlled study of ranitidine for gastroesophageal reflux symptoms during pregnancy.
    Larson JD, Patatanian E, Miner PB, Rayburn WF, Robinson MG.
    Obstet Gynecol; 1997 Jul 26; 90(1):83-7. PubMed ID: 9207819
    [Abstract] [Full Text] [Related]

  • 17. pH, healing rate, and symptom relief in patients with GERD.
    Huang JQ, Hunt RH.
    Yale J Biol Med; 1999 Jul 26; 72(2-3):181-94. PubMed ID: 10780580
    [Abstract] [Full Text] [Related]

  • 18. Clinical effectiveness and quality of life with ranitidine vs placebo in gastroesophageal reflux disease patients: a clinical experience network (CEN) study.
    Rush DR, Stelmach WJ, Young TL, Kirchdoerfer LJ, Scott-Lennox J, Holverson HE, Sabesin SM, Nicholas TA.
    J Fam Pract; 1995 Aug 26; 41(2):126-36. PubMed ID: 7636452
    [Abstract] [Full Text] [Related]

  • 19. Management of symptoms in step-down therapy of gastroesophageal reflux disease.
    Mine S, Iida T, Tabata T, Kishikawa H, Tanaka Y.
    J Gastroenterol Hepatol; 2005 Sep 26; 20(9):1365-70. PubMed ID: 16105122
    [Abstract] [Full Text] [Related]

  • 20. Treatment of gastroesophageal (acid) reflux with lansoprazole: an overview.
    Dobrilla G, Di Fede F.
    Clin Ther; 1993 Sep 26; 15 Suppl B():2-13. PubMed ID: 7911400
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.